Inovio Pharmaceuticals
INO
#8898
Rank
ยฃ0.10 B
Marketcap
ยฃ1.55
Share price
2.48%
Change (1 day)
-52.53%
Change (1 year)

Revenue for Inovio Pharmaceuticals (INO)

Revenue in 2025 (TTM): ยฃ0.14 Million

According to Inovio Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ0.13 Million. In 2024 the company made a revenue of ยฃ0.17 Million a decrease over the revenue in the year 2023 that were of ยฃ0.65 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Inovio Pharmaceuticals from 1999 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0.14 M-17.13%
2024 ยฃ0.17 M-73.43%
2023 ยฃ0.65 M-92.3%
2022 ยฃ8.48 M545.17%
2021 ยฃ1.31 M-75.82%
2020 ยฃ5.43 M73.39%
2019 ยฃ3.13 M-86.94%
2018 ยฃ24.01 M-23.13%
2017 ยฃ31.23 M8.99%
2016 ยฃ28.66 M4.7%
2015 ยฃ27.37 M307.63%
2014 ยฃ6.71 M-17.74%
2013 ยฃ8.16 M220.4%
2012 ยฃ2.54 M-59.57%
2011 ยฃ6.3 M58.32%
2010 ยฃ3.98 M-29.37%
2009 ยฃ5.63 M293.78%
2008 ยฃ1.43 M-40.86%
2007 ยฃ2.42 M36.68%
2006 ยฃ1.77 M-44.15%
2005 ยฃ3.17 M421.51%
2004 ยฃ0.6 M1250.41%
2003 ยฃ0.04 M-61.91%
2002 ยฃ0.11 M
2000 ยฃ3.72 M-31.52%
1999 ยฃ5.44 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
ยฃ47.09 B 34,433,942.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ69.11 B 50,537,640.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
ยฃ0.42 B 314,140.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ42.28 B 30,916,280.11%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
ยฃ48.18 B 35,228,624.83%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ31.76 B 23,227,647.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
ยฃ21.81 B 15,951,681.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
ยฃ0.47 M 246.52%๐Ÿ‡บ๐Ÿ‡ธ USA